Recorded on 2/27/2021
75-year-old male with extensive stage small cell lung cancer with SVC syndrome and brain metastases
Summary:
- First line chemotherapy for small cell lung cancer consists of cisplatin-etoposide or carboplatin-etoposide, with or without atezolizumab/durvalumab
- Second line therapy consists of irinotecan/topotecan with platinum-based chemotherapy or nivolumab and ipilimumab
- Aggressive radiotherapy is indicated in the setting of SVC syndrome or developing SVC syndrome and in the setting of brain metastases
- Immunotherapy for small cell lung cancer remains experimental but RCT data are promising
At PrecisCa, we are dedicated to providing expert second opinions for cancer patients to ensure they receive the best possible care. Our videos cover a wide range of topics related to oncology, including in-depth discussions on different types of cancer, treatment options, patient stories, and the latest advancements in cancer research. Whether you're a patient, caregiver, or simply seeking to expand your knowledge, our goal is to support you on your healthcare journey.
Visit our website: https://www.PrecisCa.com for more detailed information and personalized second opinions.
Stay connected with us:
Facebook: / precisca.oncology
Twitter: https://twitter.com/precisca_?lang=en
-Instagram: / precisca_oncology
-LinkedIn: / precisca
Don't forget to subscribe to our channel for regular updates and new videos. Hit the bell icon to receive notifications every time we upload. #Oncology #CancerCare #CancerSupport #CancerResearch #Health #Healthcare #CancerTreatment #CancerAwareness #PatientCare #MedicalAdvice #PrecisCa
75-year-old male with extensive stage small cell lung cancer with SVC syndrome and brain metastases
Summary:
- First line chemotherapy for small cell lung cancer consists of cisplatin-etoposide or carboplatin-etoposide, with or without atezolizumab/durvalumab
- Second line therapy consists of irinotecan/topotecan with platinum-based chemotherapy or nivolumab and ipilimumab
- Aggressive radiotherapy is indicated in the setting of SVC syndrome or developing SVC syndrome and in the setting of brain metastases
- Immunotherapy for small cell lung cancer remains experimental but RCT data are promising
At PrecisCa, we are dedicated to providing expert second opinions for cancer patients to ensure they receive the best possible care. Our videos cover a wide range of topics related to oncology, including in-depth discussions on different types of cancer, treatment options, patient stories, and the latest advancements in cancer research. Whether you're a patient, caregiver, or simply seeking to expand your knowledge, our goal is to support you on your healthcare journey.
Visit our website: https://www.PrecisCa.com for more detailed information and personalized second opinions.
Stay connected with us:
Facebook: / precisca.oncology
Twitter: https://twitter.com/precisca_?lang=en
-Instagram: / precisca_oncology
-LinkedIn: / precisca
Don't forget to subscribe to our channel for regular updates and new videos. Hit the bell icon to receive notifications every time we upload. #Oncology #CancerCare #CancerSupport #CancerResearch #Health #Healthcare #CancerTreatment #CancerAwareness #PatientCare #MedicalAdvice #PrecisCa
- Category
- Oncology

Be the first to comment